Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-15

Clinical Trial Update: Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of rotigotine transdermal patch on cardiovascular markers in idiopathic restless legs syndrome has been completed. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine patch (rotigotine)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Restless Legs Syndrome (RLS) | Phase 4 | Status: COMPLETED